Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic impact of age on outcomes of hepatic decompensation in patients with compensated cirrhosis (CHESS2102): an international, multicenter cohort study.
Liu S, Li J, Wong Y, Yim HJ, Hirooka M, Enomoto H, Xie Q, Dai E, Hanafy AS, Cao Z, Zhao L, Teh KB, Kim TH, Jung YK, Koizumi Y, Hiasa Y, Nishimura T, Iijima H, Tian Q, Guo X, Jia Y, Sun J, Liu C, Qi X. Liu S, et al. Among authors: koizumi y. MedComm (2020). 2024 Nov 3;5(11):e781. doi: 10.1002/mco2.781. eCollection 2024 Nov. MedComm (2020). 2024. PMID: 39492833 Free PMC article.
Targeted Dynamic Phospho-Proteogenomic Analysis of Gastric Cancer Cells Suggests Host Immunity Provides Survival Benefit.
Kume K, Iida M, Iwaya T, Yashima-Abo A, Koizumi Y, Endo A, Wade K, Hiraki H, Calvert V, Wulfkuhle J, Espina V, Siwak DR, Lu Y, Takemoto K, Suzuki Y, Sasaki Y, Tokino T, Petricoin E 3rd, Liotta LA, Mills GB, Nishizuka SS. Kume K, et al. Among authors: koizumi y. Mol Cell Proteomics. 2024 Oct 25;23(12):100870. doi: 10.1016/j.mcpro.2024.100870. Online ahead of print. Mol Cell Proteomics. 2024. PMID: 39461475 Free article.
Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study.
Persano M, Casadei-Gardini A, Tada T, Suda G, Shimose S, Kudo M, Rossari F, Yoo C, Cheon J, Finkelmeier F, Lim HY, Presa J, Masi G, Bergamo F, Amadeo E, Vitiello F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Iavarone MA, Cabibbo G, Montes M, Foschi FG, Vivaldi C, Soldà C, Sho T, Niizeki T, Nishida N, Steup C, Bruccoleri M, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Hiraoka A, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Mascia L, Foti S, Camera S, Piscaglia F, Scartozzi M, Cascinu S, Rimini M. Persano M, et al. Among authors: koizumi y. Oncology. 2024 Oct 11:1-13. doi: 10.1159/000541018. Online ahead of print. Oncology. 2024. PMID: 39396495
Healthcare-associated infections in Japanese hospitals: results from a large-scale multicenter point-prevalence survey in Aichi, 2020.
Morioka H, Koizumi Y, Oka K, Okudaira M, Tomita Y, Kojima Y, Watariguchi T, Watamoto K, Mutoh Y, Tsuji T, Yokota M, Shimizu J, Hasegawa C, Iwata S, Nagaoka M, Ito Y, Kawasaki S, Kato H, Kitagawa Y, Goto T, Nozaki Y, Akita K, Shimizu S, Nozawa M, Kato M, Ishihara M, Ito K, Yagi T; Research Group of Aichi Point Prevalence Survey. Morioka H, et al. Among authors: koizumi y. Infect Control Hosp Epidemiol. 2024 Oct 8:1-8. doi: 10.1017/ice.2024.130. Online ahead of print. Infect Control Hosp Epidemiol. 2024. PMID: 39376205
716 results